맹고셀티컬즈 (MGRX) 주가

맹고셀티컬즈(MGRX)는 NASDAQ에 상장된 Healthcare · Health Information Services 기업입니다. 현재가 $0.48 (+6.97%), 시가총액 $0.01B, 52주 최저~최고 $0.16 ~ $2.74.

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth c

핵심 지표

맹고셀티컬즈의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

맹고셀티컬즈 재무 요약

핵심 재무비율 · 수익성 · 성장성

자주 묻는 질문

맹고셀티컬즈(MGRX) 현재 주가는 얼마인가요?

맹고셀티컬즈의 현재 주가는 $0.48 (+6.97%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.

맹고셀티컬즈(MGRX) 시가총액은 얼마인가요?

맹고셀티컬즈의 시가총액은 약 $0.01B입니다.

맹고셀티컬즈(MGRX)은 어떤 기업인가요?

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile d